Long-Term Uveitis Rates with Bimekizumab Treatment Across Pooled Phase 2B and Phase 3 Studies in Patients with Axial Spondyloarthritis or Psoriatic Arthritis: 3-Year Update

Bimzelx (bimekizumab-bkzx) - UCB

https://asm.rheum.ca/wp-content/uploads/2026/03/2026-Poster-Abstracts-No-Images.pdf

Martin Rudwaleit; Irene van der Horst-Bruinsma; Floris A. van Gaalen; Nigil Haroon; Lianne S. Gensler; Myriam Manente; Chetan Prajapati; Katy White; Atul Deodhar; Matthew A. Brown

May 7, 2026